| Atrial Fibrillation |
1 |
1 |
| Cerebrovascular Accident |
0 |
1 |
| Rheumatic Heart Disease (RHD) |
0 |
0.82 |
| Thromboembolism |
0 |
0.75 |
| Heart |
0 |
0.69 |
| Cardiac Surgery |
0 |
0.64 |
| Heart Failure (HF) |
0 |
0.47 |
| Anticoagulation Therapy |
0 |
0.41 |
| Cardiovascular Imaging |
0 |
0.38 |
| Mitral Stenosis |
0 |
0.33 |
| Stenosis |
0 |
0.23 |
| Clinical Research |
0 |
0.12 |
| Embolism |
0 |
0.12 |
| Ischemic Stroke |
0 |
0.12 |
| Stroke Risk |
0 |
0.12 |
| Valve Replacement |
0 |
0.12 |
| Healthcare and Medical Technology |
0 |
0.1 |
| Intracranial Hemorrhage |
0 |
0.08 |
| Atrial Flutter |
0 |
0.06 |
| Direct Factor Xa Inhibitor |
0 |
0.06 |
| Echocardiography |
0 |
0.06 |
| Europe |
0 |
0.06 |
| Grant |
0 |
0.06 |
| Hemorrhage |
0 |
0.06 |
| Infarction |
0 |
0.06 |
| Meta-Analysis |
0 |
0.06 |
| Salary and Compensation |
0 |
0.06 |
| Sudden Death |
0 |
0.06 |
| Surgery |
0 |
0.06 |
| Thrombus |
0 |
0.06 |
| Vitamin |
0 |
0.06 |
| Complementary and Alternative Medicine |
0 |
0.05 |
| Myocardial Infarction (MI) |
0 |
0.05 |
| Revenue and Practice Management |
0 |
0.05 |
| Traumatic Brain Injury |
0 |
0.05 |